Juvenile diabetes.
That’s what we used to call it.
Forty years ago, and wow, typing that makes me realize how old I am, type 1 diabetes was known as juvenile diabetes. Type 2 diabetes was called adult-onset diabetes. The names …
I Know My A1C. That Should Be Enough.
“I know my A1C.”
Shouldn’t that be enough?
Quick teaching moment. The hemoglobin A1C is a measurement that averages blood sugar levels over the past two to three months. Someone whose pancreas is not on permanent vacation typically has an …
High Speed, High Stakes, High Precision: Hannah Schmidt and the Art of Balance
At 4:00 a.m. EST on February 20th, most of North America will still be asleep.
Coffee won’t be poured. Alarm clocks will still be threatening. Parents of kids with type 1 diabetes, myself included, may already be awake (but only …
GLP-1s at a Crossroads: Safety, Access, and the Future of Care
When a pharmaceutical giant sues a telehealth company over weight-loss drugs, it sounds like the beginning of a streaming documentary.
But this isn’t entertainment. It’s healthcare, and it’s complex, consequential, and evolving in very visible ways.
The recent lawsuit filed …
PBM Reform and Insulin Pricing: Progress, With Conditions
Every once in a while, a healthcare headline comes along that makes people do a double-take.
“FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients.”
That’s right. Landmark. Lower drug costs. Insulin. Accountability.
Cue the record …